Scholars@Duke publication: Erratum: Conivaptan: A dual receptor vasopressin V<inf>1a</inf>/V <inf>2</inf> antagonist (Cardiovascular Drug Reviews (2007) 25, 3, (261-279))

Erratum: Conivaptan: A dual receptor vasopressin V1a/V 2 antagonist (Cardiovascular Drug Reviews (2007) 25, 3, (261-279))

Publication , Journal Article

Steinhubl, S; Roe, M

Published in: Cardiovascular Drug Reviews

December 1, 2007

Cardiovascular Drug Reviews

0897-5957

December 1, 2007

397

APA

Chicago

ICMJE

MLA

NLM

Steinhubl, S., & Roe, M. (2007). Erratum: Conivaptan: A dual receptor vasopressin V1a/V 2 antagonist (Cardiovascular Drug Reviews (2007) 25, 3, (261-279)). Cardiovascular Drug Reviews, 25(4), 397. https://doi.org/10.1111/j.1527-3466.2007.00033.x

Steinhubl, S., and M. Roe. “Erratum: Conivaptan: A dual receptor vasopressin V1a/V 2 antagonist (Cardiovascular Drug Reviews (2007) 25, 3, (261-279)).” Cardiovascular Drug Reviews 25, no. 4 (December 1, 2007): 397. https://doi.org/10.1111/j.1527-3466.2007.00033.x.

Steinhubl, S., and M. Roe. “Erratum: Conivaptan: A dual receptor vasopressin V1a/V 2 antagonist (Cardiovascular Drug Reviews (2007) 25, 3, (261-279)).” Cardiovascular Drug Reviews, vol. 25, no. 4, Dec. 2007, p. 397. Scopus, doi:10.1111/j.1527-3466.2007.00033.x.

Cardiovascular Drug Reviews

0897-5957

December 1, 2007

397